The plenary session at the Drug Information Association’s Euromeeting in Monaco this week took the curious form of an enforced debate on pharmaceutical R&D productivity between representatives from the industry and regulatory authorities.
The motion ...
Cellzome has entered a strategic alliance with GlaxoSmithKline giving the big pharma company exclusive access to its epigenetics-based platform Episphere for drug discovery in the field of immuno-inflammatory disease.
The financial terms include an ...
Lexicon Pharmaceuticals has announced plans to offer for sale $95 million of its common stock in an underwritten public offering. It could also sell up to $14.25 million worth of shares as an over-allotment option.
Lexicon expects net proceeds from ...
Sanofi-Aventis has exercised its option to combine its animal health business Merial with Intervet/Schering-Plough Animal Health , Merck & Co 's animal health unit.
Sanofi-Aventis bought out Merck's 50% share in Merial for $4 billion last July and ...
"Tough" new measures announced last week by the department of health should help curb medicine shortages in the UK. These promise to tackle wholesaler dealer licences and manufacturers' quotas used to control the supply of medicines.
Over the past ...
